GO:0001543 |
ovarian follicle rupture |
BP |
GO:0004867 |
serine-type endopeptidase inhibitor activity |
MF |
GO:0001568 |
blood vessel development |
BP |
GO:0002019 |
regulation of renal output by angiotensin |
BP |
GO:0005615 |
extracellular space |
CC |
GO:0031702 |
type 1 angiotensin receptor binding |
MF |
GO:0001999 |
renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure |
BP |
GO:0048659 |
smooth muscle cell proliferation |
BP |
GO:0042445 |
hormone metabolic process |
BP |
GO:0007160 |
cell-matrix adhesion |
BP |
GO:0001658 |
branching involved in ureteric bud morphogenesis |
BP |
GO:0008065 |
establishment of blood-nerve barrier |
BP |
GO:0050727 |
regulation of inflammatory response |
BP |
GO:0001998 |
angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure |
BP |
GO:0008285 |
negative regulation of cell proliferation |
BP |
GO:0031703 |
type 2 angiotensin receptor binding |
MF |
GO:0043410 |
positive regulation of MAPKKK cascade |
BP |
GO:0048143 |
astrocyte activation |
BP |
GO:0030198 |
extracellular matrix organization |
BP |
GO:0045723 |
positive regulation of fatty acid biosynthetic process |
BP |
GO:0007588 |
excretion |
BP |
GO:0009409 |
response to cold |
BP |
GO:0009651 |
response to salt stress |
BP |
GO:0030162 |
regulation of proteolysis |
BP |
GO:0002018 |
renin-angiotensin regulation of aldosterone production |
BP |
GO:0040018 |
positive regulation of multicellular organism growth |
BP |
GO:0046622 |
positive regulation of organ growth |
BP |
GO:0030432 |
peristalsis |
BP |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity |
BP |
GO:0043524 |
negative regulation of neuron apoptosis |
BP |
GO:0051145 |
smooth muscle cell differentiation |
BP |
GO:0001822 |
kidney development |
BP |